All News

Janet Pope Tweet
Janetbirdope
Case control study to see if MTX is assoc with ILD in RA. Hypersensitivity pneumonitis pts were excluded. MTX use assoc with DELAYED onset of ILD so protective. let my RA pts use MTX if ILD or increased ILD risk ex male old +RF OP0036 @RheumNow @eular_org @CRASCRRheum #EULAR2020 https://t.co/NGM4t2OKTP
Patrick Kiely Tweet
pkiely500
#EULAR2020 OP0026. RITAZAREM. Rituximab superior to Aza 2mg/kg in maintaining remission in relapsing AAV. Flare rate 13% vs 38%. Note Ritux schedule is 1g every 4 months (x 5 infusions out to month 20).
Janet Pope Tweet
Janetbirdope
Can we treat GPA /ANCA vasculitis without steroids? Apparently yes +RCT by P Merkel in #EULAR2020 plenary adding avacopan-blocks C5a. Gutsy move as No steroids in one arm! ?cost effectiveness but a breakthrough @RheumNow @eular_org @CRASCRRheum https://t.co/kp7IZOaHfP
k dao Tweet
KDAO2011
Dr. R Landewe highlights #EULAR2020 #COVID19 Guidelines: 1. RMD-patients do NOT have higher risk for complications 2. Rheumatologists SHOULD BE involved in management discussions 3. Potential shortages of sDMARDS and biologics @rheumnow https://t.co/sjQubD7mJL
Mario Pompermayer, MD Tweet
pompermarioMD
Patients with RA-ILD vs RA only: More likely to be older, male, white and RF positive. More likely to have COPD, Rheumatoid nodules, erosions, extraarticular disease,⬆️antiCCP,⬆️ESR & ⬆️DAS28(CRP), DAS28(ESR), CDAI & SDAI scores #EULAR2020 #eular20 https://t.co/OhI9NKpStE
Dr. Rachel Tate Tweet
uptoTate
SAPHO or PsA with CASPAR criteria? 1/3 of SAPHO pts meet PsA criteria (particularly active or hx of psoriasis). Interestingly, most with osteitis did not meet CASPAR criteria while those with synovitis did. #EULAR2020 @RheumNow #AB0738 https://t.co/G4p6OiocE3
NIHR Leeds BRC Tweet
LeedsBRC
Congratulations from all of us at the BRC to Professor Paul Emery OBE for being awarded a Meritorious Award at EULAR 2020 #EULAR2020goesvirtual #EULAR2020 #FightingRMDsTogether https://t.co/z9T4AZ5P0u
ARD & RMD Open Tweet
ARD_BMJ
Guselkumab improved axial symptoms, over 24 weeks in active PsA patients with radiographic sacroiliitis. Post-hoc analysis from Discover1&2 studies (Prof P Helliwell). #OP0054. #EULAR2020, >GF
David Liew Tweet
drdavidliew
Can fatigue in RA vary by bDMARD used? IL-6 inhibitor treatment associated with attaining a low fatigue state (RR 1.20 vs csDMARDs). Given IL-6 secretion with HPA axis activation leads to fatigue/poor sleep, maybe something in this? RABBIT database OP0020 #EULAR2020 @RheumNow https://t.co/wzFcqdUMMV
Loreto Carmona 🖖 Tweet
carmona_loreto
17,500 people connected at moment at the largest e-Congress I could imagine #EULAR2020 #EULAR2020goesvirtual
David Liew Tweet
drdavidliew
You've got at least two good reasons not to forget about cardiovascular risk in ankylosing spondylitis. Traditional and inflammatory: it's the double whammy. Mike Nurmohamed from @Reade_020 #EULAR2020 @RheumNow https://t.co/GLH7wzvrLN
Dr Philip Robinson Tweet
philipcrobinson
Use Of TNFi Before, During And The 1stY after Pregnancy Among Women With RA: Most of the women with RA were not treated with TNFi before or in pregnancy. Women w. RA that continue Rx with TNFi through pregnancy were using certilozumab and etanercept #EULAR2020 @RheumNow Abs0302 https://t.co/bWKrpx1hx7
David Liew Tweet
drdavidliew
Increased cardiovascular risk in: - AS patients (adj HR 4.6 vs non-rheum controls) - longer disease duration of inflammatory rheum disease (7% per year) in a Spanish national multicentre project (CARMA) w 5y follow-up Martin Martinez OP0002 #EULAR2020 @RheumNow https://t.co/BffbfPfkj0
Dr Philip Robinson Tweet
philipcrobinson

Certolizumab Pegol: A Safe And Efficient Treatment In Patients With Uveitis During Pregnancy: Conclusion: CZP seems to be effective and safe in female patients with uveitis during pregnancy and neonates. Abstract AB1055 #EULAR2020 @RheumNow https://t.co/MzeZKBawTg

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×